NurOwn: Revolutionizing ALS Treatment with Biomarkers
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, has presented new biomarker data from the Phase 3 trial of its late-stage investigational ALS treatment, NurOwn, at the 2023 ALS and Related Motor Neuron Diseases Gordon Research Conference. The data showed that treatment with NurOwn significantly elevated markers of […]
Stem Cells: Unleashing Hope for Unimaginable Healing
The video above is a comprehensive exploration of the potential of stem cells in treating various health conditions. The video highlights several groundbreaking stem cell trials and the transformative impact they have had on patients’ lives. Duchenne Muscular Dystrophy: The video begins with the story of Hunter Horkheimer, a young man diagnosed with Duchenne muscular […]
Weissman Lab & Fixstars: Revolutionizing Stem Cell Research
The Weissman Lab, led by Dr. Irving Weissman, a professor at Stanford University in Pathology and Developmental Biology, is set to collaborate with Fixstars Solutions starting in July 2023. The collaboration will focus on in-situ sequencing research, specifically targeting bone marrow blood vessel cells found within mice and the stromal cells from the skeletal stem […]
Insulin Independence: Is This the Future for Type 1 Diabetes Patients?
The press release from the American Diabetes Association presents promising findings from an ongoing clinical trial of VX-880, a novel stem cell-derived islet cell therapy for individuals with type 1 diabetes (T1D). The study, presented at the 83rd Scientific Sessions of the American Diabetes Association, demonstrates the potential of this therapy as a future treatment […]
Orgenesis and UC Davis: The Dynamic Duo Transforming Cell and Gene Therapy
Orgenesis Inc., a global biotech company, and the University of California, Davis (UC Davis) have announced a partnership to deploy Orgenesis Mobile Processing Units and Labs (OMPULs) at medical and academic institutions within the University of California system. The agreement outlines a phased approach where Orgenesis will install and operate OMPULs, enabling their proprietary point-of-care […]
RoslinCT and Lykan Bioscience: The Dynamic Duo Redefining the Future of Cell and Gene Therapy
RoslinCT and Lykan Bioscience, two leading Contract Development and Manufacturing Organizations (CDMOs) in the Cell and Gene Therapy industry, have announced their integration to form a unified business that will operate under the RoslinCT brand. This integration, facilitated by GHO Capital, a global investment firm, aims to establish a dominant player in the Advanced Cell […]
Stem Cells in Space: The Unexpected Solution to Age-Related Diseases?
Age-related diseases like stroke, cancer, dementia, and other neurodegenerative conditions present significant challenges to patients and families, and pose an escalating health burden in the United States. Stem cell-based therapies may provide a solution, but creating large numbers of stem cells is challenging. To address this, scientists in regenerative medicine are using the International Space […]
How These College Interns Are Saving Lives and Breaking Records with Be The Match
Be The Match, the organization behind the world’s most diverse registry of blood stem cell and marrow donors, announced that the William G. Pomeroy Foundation has granted them an additional $300,000. This generous contribution will allow the organization to further diversify the Be The Match Registry by expanding its presence at historically Black colleges and […]
Stem Cell Game-Changer: BioCardia Receives Patent for Innovative Therapeutic Approach
Sunnyvale, California-based BioCardia, Inc. [Nasdaq: BCDA], a company specializing in the development of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced on May 9, 2023, that the United States Patent Office has awarded them Patent Number 11,642,377. The patent, titled “Bone Marrow Derived Neurokinin-1 Receptor Positive (NK1R+) Mesenchymal Stem Cells […]
Be The Match Advocates Garner $420,000+ at 2023 NY Gala for Life-Saving Blood Stem Cell Transplants
On May 4, 2023, Be The Match Foundation® hosted its annual New York Gala at the Cipriani on Broadway to raise funding for patient assistance grants, research to improve transplant outcomes, and diversification of the Be The Match Registry®. In 2022, the foundation provided $6.1 million in grants to 2,320 patients and families in need […]